FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
-0.93%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$1.52B
AUM Growth
+$1.52B
(-8.9%)
Cap. Flow
-$67.3M
Cap. Flow
% of AUM
-4.44%
Top 10 Holdings %
Top 10 Hldgs %
43.87%
Holding
86
New
7
Increased
23
Reduced
23
Closed
3
Top Buys
| 1 |
BCYC
Bicycle Therapeutics
BCYC
|
$30.5M |
| 2 |
Ultragenyx Pharmaceutical
RARE
|
$19.1M |
| 3 |
PHLT
Performant Healthcare, Inc. Common Stock
PHLT
|
$17.6M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$15.3M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$13.6M |
Top Sells
| 1 |
Arrowhead Research
ARWR
|
$38.6M |
| 2 |
Glaukos
GKOS
|
$34.7M |
| 3 |
Prothena Corp
PRTA
|
$34.1M |
| 4 |
Halozyme
HALO
|
$23.3M |
| 5 |
Genmab
GMAB
|
$15.2M |
Sector Composition
| 1 | Healthcare | 80.69% |
| 2 | Communication Services | 5.47% |
| 3 | Consumer Discretionary | 0.55% |
| 4 | Energy | 0.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Prothena Corp
PRTA
$441M
| $103M | 6.8% | 1,449,494 -478,335 | -25% | -$34.1M |
|
|
SPNE
2
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $98.5M | 6.49% | 6,263,260 +274,751 | +5% | +$4.32M |
|
|
MODN
3
DELISTED
MODEL N, INC.
MODN
| $83M | 5.47% | 2,478,532 +316,596 | +15% | +$10.6M |
|
|
4
Halozyme
HALO
$8.56B
| $60.1M | 3.96% | 1,477,496 -572,777 | -28% | -$23.3M |
|
|
XENT
5
DELISTED
Intersect ENT, Inc
XENT
| $58.1M | 3.83% | 2,136,823 -74,147 | -3% | -$2.02M |
|
6
Tandem Diabetes Care
TNDM
$845M
| $57.2M | 3.77% | 479,186 -49,420 | -9% | -$5.9M |
|
7
CareDx
CDNA
$727M
| $57.1M | 3.76% | 900,470 +4,213 | +0.5% | +$267K |
|
8
Omnicell
OMCL
$1.5B
| $52.6M | 3.46% | 354,042 -27,103 | -7% | -$4.02M |
|
9
NeoGenomics
NEO
$1.13B
| $50.9M | 3.36% | 1,055,960 -92,985 | -8% | -$4.49M |
|
10
AtriCure
ATRC
$1.84B
| $45M | 2.97% | 647,192 -125,583 | -16% | -$8.73M |
|
11
OptimizeRx
OPRX
$335M
| $43.4M | 2.86% | 507,384 -157,458 | -24% | -$13.5M |
|
12
Sutro Biopharma
STRO
$72.7M
| $41.4M | 2.73% | 2,191,439 +118,564 | +6% | +$2.24M |
|
|
13
Ultragenyx Pharmaceutical
RARE
$2.89B
| $39.8M | 2.62% | 441,159 +211,913 | +92% | +$19.1M |
|
14
Health Catalyst
HCAT
$239M
| $39.8M | 2.62% | 794,960 +5,567 | +0.7% | +$278K |
|
|
ARNA
15
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $38.5M | 2.54% | 646,162 +29,038 | +5% | +$1.73M |
|
|
CUTR
16
DELISTED
Cutera, Inc.
CUTR
| $35.8M | 2.36% | 768,727 -248,796 | -24% | -$11.6M |
|
17
Axogen
AXGN
$743M
| $35.4M | 2.33% | 2,239,261 +17,588 | +0.8% | +$278K |
|
18
Insmed
INSM
$28.8B
| $33.8M | 2.23% | 1,227,283 -158,365 | -11% | -$4.36M |
|
|
KRTX
19
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $33.7M | 2.22% | 275,644 +864 | +0.3% | +$106K |
|
20
Krystal Biotech
KRYS
$4.27B
| $33.1M | 2.18% | 633,481 +106,831 | +20% | +$5.58M |
|
|
BCYC
21
Bicycle Therapeutics
BCYC
$511M
| $30.5M | 2.01% | +732,731 | New | +$30.5M |
|
|
TPTX
22
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $30.1M | 1.98% | 452,878 +57,053 | +14% | +$3.79M |
|
23
Aldeyra Therapeutics
ALDX
$351M
| $26.2M | 1.73% | 2,985,712 -485,747 | -14% | -$4.26M |
|
|
24
SPDR S&P Biotech ETF
XBI
$5.07B
| $25.7M | 1.69% | 204,600 +121,931 | +147% | +$15.3M |
|
25
Teva Pharmaceuticals
TEVA
$21.1B
| $25.5M | 1.68% | 2,623,031 -350,061 | -12% | -$3.41M |
|